
Mireia Codina Prat
@codina_mireia
Cardióloga interesada en imagen y cardio-oncología. Hospital de Basurto.
Olot-Bilbao.
ID: 792355074701946880
https://www.linkedin.com/in/mireia-codina-prat-a974b8a2 29-10-2016 13:19:05
429 Tweet
296 Takipçi
436 Takip Edilen

🚨🚨🚨 SAVE THE DATE!! #CardioTox25 📆 4-6 noviembre 2025 📍 Hospital 🏥 La Paz, Madrid #CardioOnc Soc Esp Cardiología CardioOncologia SEC @sehh_es SEHH Joven SEOM SEOR.es GELTAMO GRUPO ESPAÑOL DE LEUCEMIA LINFOCITICA CRONICA GELMC PETHEMA







🗓️ The next webinar in the #CardioOnc series is this Thursday, titled 'Cardio-Oncology Arrhythmias: Key Concerns, Anticoagulation Strategies for Atrial Fibrillation and Rhythm & Symptom Management' 🔗 Register for free now 👉 ow.ly/ZP0p50VGa1m Expert faculty Nuno Cortez-Dias, MD PhD,



"Cardiological management of CVRF prior to treatment with fluoropyrimidines resulted in half as many cardiotoxic events but the study did not reach statistical significance". "Coronary artery calcium score did not predict chest pain" …rdiooncologyjournal.biomedcentral.com/articles/10.11…





Excited to report this important collaboration which we hope helps us understand ICI-myocarditis better, published in #EHJ today! Along with the great DrJE-Salem! EHJ Editor-in-Chief Johann Bauersachs #CardioOnc UCSF Cardiology UCSF Helen Diller Family Comprehensive Cancer Ctr academic.oup.com/eurheartj/adva…


This score will help distinguish severe from mild ICI-myocarditis. Many clinical implications‼️ In my opinion, this is one of the most clinically relevant papers on this topic to date. DrJE-Salem European Society of Cardiology Journals academic.oup.com/eurheartj/adva…


What to do in challenging cases of #ICI #myocarditis?🫀 Outstanding take-home messages from Maria Sol Andres 🇦🇷🇬🇧 at #ESCardioOnco2025 💡 📍One of the most severe immune-related adverse events➡️high mortality if not treated early 📍Risk factors: combination ICI therapy & other irAEs

🏆Servicio de Cardiología, premio al mejor caso clínico en #Ritmo25 (Soc Esp Cardiología). El estudio premiado describe la combinación del estudio electrofisiológico avanzado,que ha permitido crear mapas electroanatómicos detallados durante la arritmia, con el uso de electroporación


Reduced echo monitoring every 6 months is safe and feasible for low risk HER2+ BC patients, per #Anthony Yu et al. A key step toward evidence-based, risk-adapted monitoring. #CardioOnc #CTRCD JACC Journals Kazuhiro Sase dineshpmcc International Cardio-Oncology Society

